• Vorinostat (SAHA): Dissecting HDAC Inhibition and Mitocho...

  2025-09-28

  Explore how Vorinostat (suberoylanilide hydroxamic acid) enables advanced cancer biology research through precise HDAC inhibition, intrinsic apoptotic pathway activation, and unique insights into epigenetic modulation beyond transcriptional loss.

• Biotin-tyramide: Transforming Neurodevelopmental Imaging ...

  2025-09-27

  Explore how Biotin-tyramide revolutionizes enzyme-mediated signal amplification in neurodevelopmental research, enabling unprecedented resolution in immunohistochemistry and in situ hybridization. Discover distinct mechanistic insights, advanced application strategies, and integration with cutting-edge neurogenetic studies.

• SM-102: Optimizing Lipid Nanoparticles for Next-Gen mRNA ...

  2025-09-26

  Discover how SM-102 transforms lipid nanoparticles (LNPs) for efficient mRNA delivery and vaccine development. This article uniquely explores the molecular design, regulatory mechanisms, and translational potential of SM-102, advancing the conversation beyond predictive modeling.

• Anti Reverse Cap Analog (ARCA): Next-Generation mRNA Cap ...

  2025-09-25

  Discover how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, is transforming synthetic mRNA capping for enhanced translation and metabolic pathway engineering. This in-depth article uniquely explores ARCA’s role in advanced mRNA stability, translation initiation, and its intersection with mitochondrial metabolic regulation.

• FLAG tag Peptide (DYKDDDDK): Unlocking Precision in Recom...

  2025-09-24

  Discover how the FLAG tag Peptide (DYKDDDDK) revolutionizes recombinant protein purification and detection. This article offers a unique systems-level perspective on dissecting multi-motor protein complexes using this versatile epitope tag, with deep technical insights and practical guidance.

• Nonivamide as a TRPV1 Agonist: Novel Insights for Cancer ...

  2025-09-23

  Explore the scientific advances enabled by Nonivamide, a capsaicin analog and TRPV1 receptor agonist, in cancer cell growth inhibition and inflammation modulation. This article examines emerging molecular mechanisms and translational applications relevant to oncology and neuroimmunology.

• Canagliflozin Hemihydrate in Advanced Glucose Homeostasis...

  2025-09-22

  Explore the research applications of Canagliflozin hemihydrate, a small molecule SGLT2 inhibitor, in the context of glucose metabolism and metabolic disorder studies. This article examines its mechanistic specificity and recent evidence that distinguishes it in molecular pathway research.

• ARCA EGFP mRNA: Advances in Direct-Detection Reporter mRN...

  2025-09-19

  Explore the applications and technical benefits of ARCA EGFP mRNA as a direct-detection reporter mRNA for fluorescence-based transfection assays and mammalian cell gene expression studies. Learn how co-transcriptional capping with ARCA and Cap 0 structure enhance mRNA stability and transfection efficiency.

• Advancing Mammalian Expression: EZ Cap Cy5 Firefly Lucife...

  2025-09-18

  Explore the unique advantages of EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) for precise mRNA delivery and translation efficiency assays. This article highlights its Cap1 structure, Cy5 fluorescent labeling, and innate immune activation suppression in mammalian research applications.

• If the lack of specificity and the

  2025-04-22

  

  If the lack of specificity and the high pleiotropy may represent a problem in view of the potential chemotherapeutic features of autophagy-inducing agents, it Biotin-tyramide may switch into an advantage in the case of chemopreventive strategies. In fact, as non-pharmacologic interventions such as

• Compound was docked into the active site of Aurora B

  2025-04-22

  

  Compound was docked into the active site of Aurora B kinase using Tripos sybyl-X ver. 2.1.1. The crystal structure of human Aurora B kinase cocrystallized with its potent inhibitor VX-680 was used for the docking analysis (PDB ID: ). The most likely binding conformations were selected based on the

• In many cells AR mediated activation of PLC has been

  2025-04-21

  

  In many Y-27632 dihydrochloride α1-AR mediated activation of PLC has been shown to be the downstream process for NA-induced signalling. The activated PLC initiates subsequent signalling by breakdown of PIP2 to IP3 and DAG (Fisher and Agranoff, 1987) and the process continues. To confirm if such mech

• Recent studies have indicated that V

  2025-04-19

  

  Recent studies have indicated that V-ATPase activity negatively regulates vacuolar fusion in vivo[17]. Since we have demonstrated that the pah1Δ Biotin-tyramide have a more acidic vacuolar pH than the WT cells, and the genes involved in the pump activity are upregulated compared to WT, the pah1Δ cel

• Our outcrossing data confirmed that ACL and

  2025-04-19

  

  Our outcrossing data confirmed that ACL1 and ACL2 have important temporal and spatial functions in ascospore delimitation in G. zeae. When each ACL deletion mutant was used as male for outcrossing, nuclear division and spore delimitation were not properly progressed in most asci. Ascospores that con

• br Crystal structure ACLY protein is a

  2025-04-19

  

  Crystal structure ACLY protein is a homotetramer of four identical subunits [9]. Each polypeptide chain contains 1101 amino-acid residues [10]. The crystal structure of full-length ACLY protein is yet unresolved. However, Sun et al. recently succeeded in crystallizing chymotrypsin-truncated human

14119 records 1/942 page Next 12345 下5页 Last page